| 1st Nov 2023 7:00 am |
RNS |
POLB 001 Oncology Programme Update Meeting |
| 26th Oct 2023 7:00 am |
RNS |
SAB Endorses Influenza Drug Targets |
| 17th Oct 2023 7:00 am |
RNS |
Poolbeg Partners with a Nasdaq-Listed Biopharma |
| 29th Sep 2023 7:00 am |
RNS |
Favourable Conclusion of Patent Opposition |
| 20th Sep 2023 7:00 am |
RNS |
Immunomodulator I Patent Portfolio Strengthened |
| 19th Sep 2023 7:00 am |
RNS |
Immunomodulator I Patent Opposition Withdrawal |
| 13th Sep 2023 7:00 am |
RNS |
Interim results for the six months to 30 June 2023 |
| 29th Jun 2023 7:00 am |
RNS |
AI led programme identifies influenza drug targets |
| 22nd Jun 2023 7:00 am |
RNS |
Oral Vaccine Programme Moves Forward |
| 24th May 2023 7:00 am |
RNS |
Board Appointment |
| 11th May 2023 2:27 pm |
RNS |
Results of Annual General Meeting |
| 12th Apr 2023 7:00 am |
RNS |
Annual Report & AGM Notice |
| 30th Mar 2023 7:00 am |
RNS |
Results for the year ended 31 December 2022 |
| 10th Mar 2023 7:00 am |
RNS |
Notification of Major Holdings |
| 9th Mar 2023 3:51 pm |
RNS |
Notification of Major Holdings |
| 8th Mar 2023 7:00 am |
RNS |
POLB 001 patent portfolio strengthened |
| 2nd Mar 2023 11:05 am |
RNS |
Second Price Monitoring Extn |
| 2nd Mar 2023 11:00 am |
RNS |
Price Monitoring Extension |
| 2nd Mar 2023 7:00 am |
RNS |
Positive Results POLB001 LPS Human Challenge Trial |
| 16th Jan 2023 7:00 am |
RNS |
Strategic expansion of POLB 001 into oncology |
| 9th Jan 2023 9:05 am |
RNS |
Second Price Monitoring Extn |
| 9th Jan 2023 9:00 am |
RNS |
Price Monitoring Extension |
| 9th Jan 2023 7:00 am |
RNS |
Positive Initial Data Analysis in POLB 001 Trial |
| 22nd Dec 2022 10:48 am |
EQS |
Poolbeg Pharma identifies new RSV drug candidates |
| 21st Dec 2022 7:00 am |
RNS |
Poolbeg identifies novel RSV drug candidates |
| 15th Dec 2022 9:49 am |
EQS |
Poolbeg Pharma makes 'interesting addition to existing collaboration' |
| 14th Dec 2022 7:00 am |
RNS |
Metabolic diseases oral delivery licence signed |
| 12th Dec 2022 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 12th Dec 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 12th Dec 2022 12:00 pm |
EQS |
Poolbeg Pharma receives initial results from human challenge clinical study |
| 12th Dec 2022 7:00 am |
RNS |
POLB 001 LPS human challenge trial completed |
| 29th Nov 2022 7:00 am |
RNS |
Influenza AI model build completed |
| 21st Nov 2022 11:37 am |
EQS |
Poolbeg Pharma wins first non-dilutive grant funding |
| 18th Nov 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 17th Nov 2022 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 17th Nov 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 17th Nov 2022 7:00 am |
RNS |
Capital Markets Day |
| 15th Nov 2022 10:36 am |
RNS |
Poolbeg-led consortium awarded EUR 2.3m grant |
| 9th Nov 2022 1:53 pm |
EQS |
Poolbeg Pharma makes virus 'breakthrough' using AI drug discovery technology |
| 8th Nov 2022 7:00 am |
RNS |
AI programme yields novel RSV drug targets |
